© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography
The Heart Institute, Good Samaritan Hospital and Division of Cardiology, University of Southern California, Los Angeles, CA, USA
* Corresponding author. Address for correspondence: Heart Institute Research, Good Samaritan Hospital, 1225 Wilshire Boulevard, Los Angeles, CA 90017, USA. Tel.: +1-213-977-4050; Fax: +1-213-977-4107.
Background: Costs for large animal studies have escalated. Therefore there is a need to develop small animal models of non-ischemic cardiac failure and accurate non-invasive techniques that will allow serial quantitation of left ventricular function. Objectives: The purpose of our study was to determine the efficacy and reliability of adriamycin for inducing cardiomyopathy in rats. We hypothesized that high frequency transthoracic 2-dimensional and M-mode echocardiography would allow for serial testing of cardiac function in this small animal model. Methods: Adriamycin was administered at a dose of 2.5 mg/kg intravenously once a week for 10 weeks in 54 rats. Transthoracic echocardiography by use of a 7.5 MHz transducer was performed in 19 rats at baseline and additionally at 12 weeks after beginning of adriamycin therapy to measure left ventricular dimensions and calculate fractional shortening. Results: The mortality rate during the treatment period was 11%, but increased to 52% at 13 weeks. Transthoracic echocardiography provided adequate visualization of left ventricular dimensions and cardiac function in a parasternal short axis view. In follow-up echocardiography, pericardial effusion was detected in 8/19 rats (42%). Compared to baseline, end-diastolic diameters increased from 0.56±0.06 to 0.64±0.08 mm (p<0.001), end-systolic diameters increased from 0.27±0.03 to 0.42±0.08 mm (p<0.001), and fractional shortening decreased from 52.8±4.0 to 34.3±7.1% (p<0.001) at 12 weeks. Electron microscopy in a subset of rats revealed cardiomyocyte degeneration, mitochondrial and sarcoplasmatic reticular edema, numerous intracellular vacuoles and ‘onion-ring’ shaped mitochondrial cristae, characteristic for adriamycin cardiotoxicity in human patients. Conclusion: Adriamycin at an intravenous dose of 2.5 mg/kg over 10 weeks can be used to create a reliable model of non-ischemic dilated cardiomyopathy with a high success rate. For in-vivo diagnostic purposes, transthoracic echocardiography provides a reliable technique to non-invasively assess cardiac function quantitatively and qualitatively in follow-up studies in rat cardiomyopathy. This small animal model can easily be used for testing new therapeutic strategies in cardiac failure.
KEYWORDS Cardiomyopathy; Adriamycin; Rats; Echocardiography
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. H. Little, A. Saw, Y. Bai, J. Dow, P. Marjoram, B. Simkhovich, J. Leeka, L. Kedes, R. A. Kloner, and C. Poizat Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase II{delta}B in Cardiomyocyte Survival in Cardiomyopathy J. Biol. Chem., September 11, 2009; 284(37): 24857 - 24868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Schwarz, T. Tussing, E. Skobel, B. Klosterhalfen, D. Domanski, and J. E. Fuess Application of Zinc-bis-(DL-Hydrogensaspartate) Does Not Reduce Apoptotic Cell Death in Myocardial Infarction in the Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 215 - 221. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Aupperle, J. Garbade, A. Schubert, M. Barten, S. Dhein, H.-A Schoon, and F.-W Mohr Effects of Autologous Stem Cells on Immunohistochemical Patterns and Gene Expression of Metalloproteinases and Their Tissue Inhibitors in Doxorubicin Cardiomyopathy in a Rabbit Model Vet. Pathol., July 1, 2007; 44(4): 494 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Hacker, S. H. McKiernan, P. S. Douglas, J. Wanagat, and J. M. Aiken Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H304 - H311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Agbulut, M.-L. Menot, Z. Li, F. Marotte, D. Paulin, A. A. Hagege, C. Chomienne, J.-L. Samuel, and P. Menasche Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy Cardiovasc Res, May 1, 2003; 58(2): 451 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Nelson, B. L. Roeder, J. C. Carmen, F. Roloff, and W. G. Pitt Ultrasonically Activated Chemotherapeutic Drug Delivery in a Rat Model Cancer Res., December 15, 2002; 62(24): 7280 - 7283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Prunier, R. Gaertner, L. Louedec, J.-B. Michel, J.-J. Mercadier, and B. Escoubet Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H346 - H352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Collins, C. E. Korcarz, S. G. Shroff, J. E. Bednarz, R. C. Fentzke, H. Lin, J. M. Leiden, and R. M. Lang Accuracy of echocardiographic estimates of left ventricular mass in mice Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1954 - H1962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sjaastad, O. M. Sejersted, A. Ilebekk, and R. Bjornerheim Echocardiographic criteria for detection of postinfarction congestive heart failure in rats J Appl Physiol, October 1, 2000; 89(4): 1445 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Schwarz, M. T. Speakman, and R. A. Kloner A New Model of Ventricular Plication: A Suturing Technique to Decrease Left Ventricular Dimensions, Improve Contractility, and Attenuate Ventricular Remodeling After Myocardial Infarction in the Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(1): 41 - 49. [Abstract] [PDF]
|
|